Search Results for agency_names:"National Institutes of Health"

The National Institute of Neurological Disorders and Stroke will hold a meeting of the National Advisory Neurological Disorders and Stroke Council on May 14-15, 2025. The meeting will be open to the public on May 14 from 10:00 a.m. to 5:00 p.m., with discussions on administrative matters and program developments, and it will be available via videocast. The session on May 15, from 10:00 a.m. to 5:00 p.m., will be closed to the public to discuss confidential grant applications. Those wishing to attend or needing special accommodations should contact Dr. Andrea Meredith.

The National Institute of Diabetes and Digestive and Kidney Diseases is holding a closed meeting on February 12, 2025, to review grant applications. This meeting will be conducted virtually and is closed to the public to protect confidential information and personal privacy. The review of the applications involves fellowships in diabetes, endocrinology, and metabolic diseases. For more details, Dr. Thomas A. Tatham is the contact person at the National Institutes of Health.

The National Center for Advancing Translational Sciences is holding a closed meeting on March 9, 2021, to evaluate grant applications. This meeting will be virtual and not open to the public because it will discuss confidential information, including trade secrets and personal data. The meeting, aimed at assessing applications for the CTSA Revision Award, will be managed by Dr. Rahat Khan, a Scientific Review Officer from the National Institutes of Health.

The National Institutes of Health (NIH) is announcing the availability of a government-owned invention for licensing. This invention involves monoclonal antibodies that can neutralize Epstein-Barr virus (EBV), which causes infectious mononucleosis and various cancers. These antibodies offer potential uses in diagnostics, therapeutics, and vaccine research. Interested parties can contact Peter Soukas for licensing opportunities or collaborative research to further develop and commercialize this technology.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting to discuss grant applications. This meeting, scheduled for January 28, 2025, will focus on the development of tools to combat antibiotic-resistant bacteria, and it will not be open to the public to protect confidential information. The meeting will take place online and is organized by Dr. Maryam Feili-Hariri, a Scientific Review Officer at the institute.

The National Institutes of Health, part of the U.S. Department of Health and Human Services, has announced an invention available for licensing. This invention is a high-throughput COVID-19 diagnostic test that uses next-generation sequencing to simultaneously detect the virus and the host's response. It aims to provide accurate and fast testing on a large scale, with potential applications in detecting various infectious organisms. The technology reduces reagent use and can also help predict the severity of the disease based on gene expression.

The National Institutes of Health (NIH) has restructured its All of Us Research Program, moving it from the NIH Office of the Director to the Division of Program Coordination, Planning, and Strategic Initiatives. This reorganization was approved by the Secretary of Health and Human Services in December 2024. Additionally, they established a new program office focused on environmental health impacts on children. The changes aim to improve research efforts and enhance collaboration among different health initiatives.

The National Toxicology Program (NTP) has released draft technical reports on sodium tungstate dihydrate, di-n-butyl phthalate, and di(2-ethylhexyl) phthalate for peer review. A virtual meeting for this peer review will take place on April 2, 2021, and is open to the public. People interested in attending or making oral comments must register by specified deadlines. Written comments can also be submitted on the draft reports, and the details for participation and access are available on the NTP website.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development announced a closed meeting scheduled for April 17, 2025. The meeting will run from 10:00 a.m. to 5:00 p.m. and will be held virtually. It is organized to review and evaluate grant applications related to pregnancy, perinatology, and pediatrics. The discussions will include sensitive information, such as confidential trade secrets and personal information, hence the closure to the public.

The National Institutes of Health announced a closed meeting for the National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel to review grant applications. The meeting is scheduled for April 15, 2025, from 11:00 a.m. to 1:00 p.m. and will be conducted virtually. The meeting will be closed to the public because discussions may involve confidential information such as trade secrets and personal details that require privacy protection.